When the first diagnosis is not the final diagnosis

Anterior mediastinal masses in children immediately raise a familiar differential diagnosis: lymphoma, germ cell tumors, and, far less commonly, thymoma. Yet occasionally a patient's clinical course refuses to fit the initial pathology, reminding us that medicine demands continual reassessment rather than diagnostic anchoring.

In this remarkable case report, Çalışkan Kamış and colleagues describe a 13-year-old girl who presented with severe respiratory distress caused by a large anterior mediastinal mass. Initial needle biopsy was compromised by crush artifact and demonstrated a T-cell-rich infiltrate with focal keratin positivity, findings interpreted as compatible with a thymic epithelial neoplasm. Because of her rapidly deteriorating condition, empiric chemotherapy was initiated for presumed advanced thymoma.

The clinical picture, however, continued to evolve.

Comprehensive imaging demonstrated extensive disease extending well beyond the mediastinum, including generalized lymphadenopathy, hepatic lesions, and skeletal involvement. The emergence of a new submandibular lymph node created an opportunity for repeat tissue sampling. This second biopsy fundamentally changed the diagnosis.

Immunohistochemistry demonstrated diffuse expression of CD3, CD5, CD8, CD45, and BCL-2 with a high Ki-67 proliferation index while lacking epithelial markers and markers of lymphoid immaturity. Collectively, these findings supported a mature T-cell neoplasm most consistent with T-cell prolymphocytic leukemia (T-PLL). Although molecular confirmation was unavailable, multidisciplinary integration of clinical presentation, imaging, pathology, and immunophenotyping established the diagnosis with reasonable confidence.

The rarity of this presentation cannot be overstated.

T-PLL is an uncommon, highly aggressive mature T-cell leukemia that almost exclusively affects older adults. Pediatric cases are extraordinarily rare, and presentation as a bulky anterior mediastinal mass without prominent lymphocytosis represents an exceptional diagnostic pitfall. The case illustrates how limited biopsy specimens, sampling error, and overlapping immunophenotypic findings may initially misdirect the diagnostic process.

Perhaps the greatest educational value lies not in the rarity of the disease itself but in the clinical reasoning it demonstrates. Diagnostic certainty should remain dynamic. When pathology, imaging, and clinical evolution fail to align, repeat biopsy and renewed multidisciplinary discussion become essential rather than optional.

The authors also acknowledge an important limitation. Cytogenetic and molecular confirmation, including characteristic chromosome 14 abnormalities or TCL1-related testing, was unavailable. Their careful discussion appropriately frames the diagnosis as "most consistent with T-PLL," illustrating commendable diagnostic transparency while remaining aligned with current WHO and International T-PLL Study Group recommendations.

For clinicians caring for pediatric patients with mediastinal tumors, this report reinforces a timeless lesson: the first biopsy does not always provide the final answer. Maintaining diagnostic flexibility can be lifesaving, particularly when clinical progression contradicts the presumed diagnosis.

Clinical Take-Home Message

When pediatric mediastinal masses exhibit atypical clinical behavior or discordance between pathology and imaging, clinicians should resist diagnostic anchoring. Repeat biopsy, expanded immunophenotyping, and multidisciplinary clinicopathologic correlation may reveal rare but clinically important alternative diagnoses such as pediatric T-cell prolymphocytic leukemia.

Journal of Medical Case Reports is the world's first international, PubMed-listed medical journal devoted to publishing case reports from all medical disciplines and will consider any original case report that expands the field of general medical knowledge, and original research relating to case reports. The journal is open access and strongly endorses the CARE guidelines for case reports, requiring authors to submit populated CARE checklists with submissions to improve transparency in reporting.